Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic 129-Xe MRI Study of Single Inhaler FF/UMEC/VI Effects in COPD Patients
NCT07192016Phase 4Recruiting
- Sponsor
- Western University
- Start
- Apr 2026
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone, umeclidinium, vilanterol in chronic obstructive pulmonary disease (COPD), sponsored by Western University. Started Apr 2026; status: recruiting.
02
Drugs
fluticasoneumeclidiniumvilanterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07192016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07192016.